About Targenomix
Targenomix is a Healthcare company based in Potsdam (Germany) founded in 2013, and was acquired by Bayer in November 2022. Uses systems biology approach to identify small molecules. The company has 31 employees. Its chief executive, as recorded, is Sebastian Klie. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is Targenomix GmbH.
Company details
Targenomix was founded in 2013 and is based in Potsdam, Germany. Operations center on biotechnology, where small molecule discovery and development are pursued through integrated methods combining systems biology with molecular biology, cell biology, genetics, biochemistry, metabolomics, and transcriptomics. Data integration and computational solutions are incorporated to support these processes. The resulting technologies are directed toward enhancing crop production and quality.
- Headquarters Potsdam, Germany
- Employees 31
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website targenomix.com
- Acquired by Bayer (Nov 2022)
- Legal Name Targenomix Gmbh
Investors in Targenomix
Targenomix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bayer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science solutions for healthcare and agriculture are delivered. | 1863 | bayer.com | Leverkusen, Germany |
Investor details for Targenomix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Targenomix
1 people are tracked at Targenomix (1 in leadership); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Sebastian Klie | CEO & MD | Leadership |
Complete people profiles for Targenomix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Targenomix
2 dated milestones of Targenomix across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Targenomix is founded.
- Exit Acquired by Bayer.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Targenomix
Complete news archive for Targenomix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Targenomix
Targenomix was founded in 2013.
Targenomix is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
Sebastian Klie is the CEO of Targenomix, as recorded in our data.
Targenomix has 31 employees.
Targenomix was founded in 2013 and is based in Potsdam, Germany. Operations center on biotechnology, where small molecule discovery and development are pursued through integrated methods combining systems biology with molecular biology, cell biology, genetics, biochemistry, metabolomics, and transcriptomics. Data integration and computational solutions are incorporated to support these processes. The resulting technologies are directed toward enhancing crop production and quality.
Targenomix has 1 investor. Key investors include Bayer.
Targenomix operates through Targenomix Gmbh.
Yes. Targenomix was acquired by Bayer in November 2022.